117 related articles for article (PubMed ID: 10504007)
1. Psychological variables as predictors of rubella antibody titers and fatigue--a prospective, double blind study.
Morag M; Morag A; Reichenberg A; Lerer B; Yirmiya R
J Psychiatr Res; 1999; 33(5):389-95. PubMed ID: 10504007
[TBL] [Abstract][Full Text] [Related]
2. Influence of socioeconomic status on behavioral, emotional and cognitive effects of rubella vaccination: a prospective, double blind study.
Morag M; Yirmiya R; Lerer B; Morag A
Psychoneuroendocrinology; 1998 May; 23(4):337-51. PubMed ID: 9695135
[TBL] [Abstract][Full Text] [Related]
3. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
[TBL] [Abstract][Full Text] [Related]
5. [Rubella immunization with HPV77DE5 and RA 27/3 vaccines of 11 to 16-year-old girls: studies of antibody formation and antibody resistance after 4 and 8 years].
Gitmans U; Enders G; Glück H; Harm B; Lindemann L
Immun Infekt; 1983 May; 11(3):79-90. PubMed ID: 6676174
[TBL] [Abstract][Full Text] [Related]
6. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.
Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F
J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777
[TBL] [Abstract][Full Text] [Related]
7. Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina.
Pardon F; Vilariño M; Barbero P; Garcia G; Outon E; Gil C; Vera A; Rossi S; Distefano A
J Infect Dis; 2011 Sep; 204 Suppl 2():S745-7. PubMed ID: 21954276
[TBL] [Abstract][Full Text] [Related]
8. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
Lin DB; Kao CL; Lee CY
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
[TBL] [Abstract][Full Text] [Related]
9. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
Crovari P; Gabutti G; Giammanco G; Dentico P; Moiraghi AR; Ponzio F; Soncini R
Vaccine; 2000 Jun; 18(25):2796-803. PubMed ID: 10812221
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
[TBL] [Abstract][Full Text] [Related]
11. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women.
Tingle AJ; Mitchell LA; Grace M; Middleton P; Mathias R; MacWilliam L; Chalmers A
Lancet; 1997 May; 349(9061):1277-81. PubMed ID: 9142061
[TBL] [Abstract][Full Text] [Related]
12. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
Hoppe G
Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
[TBL] [Abstract][Full Text] [Related]
13. How to determine protective immunity in the post-vaccine era.
Charlton CL; Lai FY; Dover DC
Hum Vaccin Immunother; 2016 Apr; 12(4):903-6. PubMed ID: 26811063
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
[TBL] [Abstract][Full Text] [Related]
15. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
Enders G; Nickerl U
Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
[TBL] [Abstract][Full Text] [Related]
16. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine].
Ozaki T; Nishimura N; Gotoh K; Ohe K; Funahashi K; Maeda K; Okuno Y
Kansenshogaku Zasshi; 2011 May; 85(3):250-5. PubMed ID: 21706844
[TBL] [Abstract][Full Text] [Related]
17. Immune status of health care personnel & post vaccination analysis of immunity against rubella in an eye hospital.
Rajasundari TA; Chandrasekar K; Vijayalakshmi P; Muthukkaruppan V
Indian J Med Res; 2006 Nov; 124(5):553-8. PubMed ID: 17213524
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees.
Toyoda M; Ihara T; Nakano T; Ito M; Kamiya H
Vaccine; 1999 Apr; 17(15-16):2051-8. PubMed ID: 10217606
[TBL] [Abstract][Full Text] [Related]
19. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
McLean HQ; Fiebelkorn AP; Ogee-Nwankwo A; Hao L; Coleman LA; Adebayo A; Icenogle JP
Vaccine; 2018 Sep; 36(38):5732-5737. PubMed ID: 30107992
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.
Su SB; Guo HR
Am J Trop Med Hyg; 2002 Nov; 67(5):549-53. PubMed ID: 12479561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
